Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma by Joy M. Davis, Tullia Rushton, Felicity Nsiah, Rebecca L. Stone, Anna L. Beavis, Stéphanie L. Gaillard, Alice Dobi, Amanda N. Fader

Get full text

Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy by Yao-An Shen, Jin Jung, Geoffrey D. Shimberg, Fang-Chi Hsu, Yohan Suryo Rahmanto, Stephanie L. Gaillard, Jiaxin Hong, Jürgen Bosch, Ie-Ming Shih, Chi-Mu Chuang, Tian-Li Wang

Get full text

Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer by Alexandra N. Aquino-Acevedo, Hope Knochenhauer, Yesenia Castillo-Ocampo, Melanie Ortiz-León, Yadiel A. Rivera-López, Camily Morales-López, Melanie E. Cruz-Robles, Elvin R. Hernández-Cordero, Shonagh Russell, Regina Whitaker, Margarita Bonilla-Claudio, Dung-Tsa Chen, Julie Dutil, Stephanie L. Gaillard, John S. Yi, Rebecca A. Previs, Guillermo N. Armaiz-Pena

Get full text

Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer by John Wright, Stephanie Lheureux, Ilaria Colombo, Ramy Gadalla, Pamela S Ohashi, Xuan Li, Lisa Wang, Matthew S Block, David G Brooks, Andrea Jewell, Carolyn McCourt, Eugenia Girda, Sarah Temkin, Gini F Fleming, Linda Duska, Daniela E Matei, Panagiotis A Konstantinopoulos, Ben X Wang, Stephanie L Gaillard, Michael McHale, Floor J Backes, Theresa L Werner, Siobhan Kehoe, Rachel Wildman, Shirin Soleimani, Scott Lien, Trevor Pugh

Get full text